[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. Director and President/CEO Peter J. Arduini reported two dispositions of common stock that occurred on 09/01/2025. The filings show 5,874 shares and 5,472 shares were disposed of at $73.73 per share, for a total of 11,346 shares removed via withholding to satisfy tax obligations tied to the vesting of restricted stock units.

After these transactions Mr. Arduini beneficially owned 173,354 shares on one reported line and 167,882 shares on the other, with all holdings reported as direct ownership. The form indicates the share withholding was used solely to meet tax withholding from RSU vesting.

Positive

• Transparent disclosure by the CEO and director consistent with Section 16 reporting
• Withholding to satisfy taxes indicates RSU vesting rather than an open-market sale, reducing signaling risk

Negative

• Total reduction of 11,346 shares from the reported holdings due to tax withholding
• Dispositions occurred at $73.73 per share, reducing the executive's absolute share count

Insights

Financial Analyst

TL;DR: CEO sold a modest number of shares via tax-withholding after RSU vesting; transaction size is routine and non-dilutive.

The disposition of 11,346 shares at $73.73 each reflects tax withholding on vested restricted stock units rather than an open-market sale. This is a commonplace liquidity mechanism for executives that does not indicate a change in strategic ownership intent. The remaining direct holdings reported (173,354 and 167,882 shares) keep executive ownership material relative to typical insider stakes, though absolute impact on share supply is minimal. No derivative activity or additional compensatory grants are disclosed in this Form 4.

Corporate Governance Expert

TL;DR: Reporting is timely and consistent with corporate governance norms; withholding to cover taxes is standard practice.

The Form 4 shows transparent disclosure of RSU-related withholding by the President and CEO, filed as an individual reporting person who is also a director. Using share withholding to satisfy tax obligations aligns with common executive compensation practices and avoids open-market transactions that could signal intent. The filing includes clear ownership lines marked as direct; there are no indications of hedging, pledging, or 10b5-1 plan execution noted on this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arduini Peter J

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/01/2025		F		5,874(1)	D	$73.73	173,354	D
Common Stock, par value $0.01 per share	09/01/2025		F		5,472(1)	D	$73.73	167,882	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did GEHC insider Peter J. Arduini report on Form 4?

He reported two dispositions totaling 11,346 shares of GEHC common stock, executed on 09/01/2025, at $73.73 per share related to RSU tax withholding.

Were these share sales open-market transactions or tax withholdings for RSUs?

The Form 4 states the share movements were withholding of shares to satisfy tax obligations in connection with the vesting of restricted stock units.

How many shares does Peter J. Arduini own after the reported transactions?

The filing reports beneficial ownership amounts of 173,354 shares and 167,882 shares on the two reported lines, both shown as direct ownership.

Did the Form 4 disclose any derivative transactions or hedging activity for GEHC?

No. The Form 4 contains only non-derivative security dispositions and the explanation notes tax withholding for RSU vesting; no derivatives or hedging are reported.

Does the filing indicate a 10b5-1 trading plan was used for these transactions?

No 10b5-1 plan box or instruction is checked for these specific transactions in the provided content.

What price were the withheld shares valued at in the Form 4?

Each reported disposition line lists a price of $73.73 per share.